Evidence map›Paper›PMID 23019329›Full record

ArticleThe Journal of biological chemistry2012

The potassium channel interacting protein 3 (DREAM/KChIP3) heterodimerizes with and regulates calmodulin function.

Pradeep L Ramachandran, Theodore A Craig, Elena A Atanasova, Gaofeng Cui, Barbara A Owen, H Robert Bergen, Georges Mer, Rajiv Kumar

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Pradeep L RamachandranDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota 55905, USA.
Theodore A Craig
Elena A Atanasova
Gaofeng Cui
Barbara A Owen
H Robert Bergen
Georges Mer
Rajiv Kumar
Mayo Clinic · USHypertension Institute · US

Funding

Structure of Sclerostin Protein ComplexesR21AR060869 · NIAMS · MAYO CLINIC ROCHESTER · PI KUMAR, RAJIV · 2011 to 2012
$390k
1,25-Dihydroxyvitamin D and vitamin D Receptor Function in the Zebrafish SkeletonR21AR058003 · NIAMS · MAYO CLINIC ROCHESTER · PI KUMAR, RAJIV · 2010 to 2011
$383k
NIAMS NIH HHS AR-058003NIAMS NIH HHS AR-60869NIAMS NIH HHS R21 AR058003NIAMS NIH HHS R21 AR060869
6 · The paper itself

Abstract

Downstream regulatory element antagonistic modulator (DREAM/KChIP3), a neuronal EF-hand protein, modulates pain, potassium channel activity, and binds presenilin 1. Using affinity capture of neuronal proteins by immobilized DREAM/KChIP3 in the presence and absence of calcium (Ca(2+)) followed by mass spectroscopic identification of interacting proteins, we demonstrate that in the presence of Ca(2+), DREAM/KChIP3 interacts with the EF-hand protein, calmodulin (CaM). The interaction of DREAM/KChIP3 with CaM does not occur in the absence of Ca(2+). In the absence of Ca(2+), DREAM/KChIP3 binds the EF-hand protein, calcineurin subunit-B. Ca(2+)-bound DREAM/KChIP3 binds CaM with a dissociation constant of ∼3 μM as assessed by changes in DREAM/KChIP3 intrinsic protein fluorescence in the presence of CaM. Two-dimensional (1)H,(15)N heteronuclear single quantum coherence spectra reveal changes in chemical shifts and line broadening upon the addition of CaM to (15)N DREAM/KChIP3. The amino-terminal portion of DREAM/KChIP3 is required for its binding to CaM because a construct of DREAM/KChIP3 lacking the first 94 amino-terminal residues fails to bind CaM as assessed by fluorescence spectroscopy. The addition of Ca(2+)-bound DREAM/KChIP3 increases the activation of calcineurin (CN) by calcium CaM. A DREAM/KChIP3 mutant incapable of binding Ca(2+) also stimulates calmodulin-dependent CN activity. The shortened form of DREAM/KChIP3 lacking the NH(2)-terminal amino acids fails to activate CN in the presence of calcium CaM. Our data demonstrate the interaction of DREAM/KChIP3 with the important EF-hand protein, CaM, and show that the interaction alters CN activity.

Indexed as

CalcineurinCalciumCalmodulinHumansKv Channel-Interacting ProteinsMutationProtein BindingProtein MultimerizationProtein Structure, TertiaryRepressor ProteinsCalcineurinCalciumCalmodulinKCNIP3 protein, humanKv Channel-Interacting ProteinsRepressor Proteins

Identifiers

PMID23019329
PMCPMC3501030
OpenAlexW2019556312

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.